CNS PHARMACEUTICALS INC (CNSP) Forecast, Price Target & Analyst Ratings

NASDAQ:CNSP • US18978H5081

Current stock price

2.44 USD
-0.12 (-4.69%)
At close:
2.45 USD
+0.01 (+0.41%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CNS PHARMACEUTICALS INC (CNSP).

Forecast Snapshot

Consensus Price Target

Price Target
$53.04
+ 2,073.77% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 30, 2026
Period
Q4 / 2025
EPS Estimate
-$5.19
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$53.04
Upside
+ 2,073.77%
From current price of $2.44 to mean target of $53.04, Based on 8 analyst forecasts
Low
$20.20
Median
$53.04
High
$88.20

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for CNSP. The average price target is 53.04 USD. This implies a price increase of 2073.77% is expected in the next year compared to the current price of 2.44.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CNSP Current Analyst RatingCNSP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

CNSP Historical Analyst RatingsCNSP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
CNSP was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CNSP.
In the previous month the buy percentage consensus was at a similar level.
CNSP was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-09-12Maxim GroupUpgrade Hold -> Buy
2025-03-25Maxim GroupDowngrade Buy -> Hold
2024-09-10Maxim GroupUpgrade Hold -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 30, 2026
Period
Q4 / 2025
EPS Estimate
-$5.19
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
95.32%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
11.09%

Next Earnings Summary

CNSP is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is -5.19 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
CNSP revenue by date.CNSP revenue by date.
N/AN/AN/AN/AN/A
37.36%		N/A
28.78%
EBITDA
YoY % growth
CNSP ebitda by date.CNSP ebitda by date.
N/AN/A-3.83M-9.44M
-146.48%		-14.48M
-53.39%		-15.26M
-5.39%		-18.861M
-23.60%		-14.899M
21.01%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CNSP ebit by date.CNSP ebit by date.
-220K-880K
-300.00%		-3.83M
-335.23%		-9.45M
-146.74%		-14.49M
-53.33%		-15.27M
-5.38%		-18.865M
-23.54%		-14.902M
21.01%		N/A
12.04%		N/A
-1.65%		N/A
-59.66%		N/A
329.97%		N/A
92.34%		N/A
43.39%
Operating Margin
CNSP operating margin by date.CNSP operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CNSP eps by date.CNSP eps by date.
N/AN/AN/A-513,000.00
-408.02%		-486,000.00
5.26%		N/A
100.00%		N/A
-17.65%		N/A
-3,808.00%		N/A
94.15%		N/A
76.92%		N/A
0.79%		N/A
-295.54%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-5.19
95.32%		-5.48-1.24
80.62%		-1.36
76.45%		-1.40
73.08%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-2.907M
9.16%		-3.064M
29.36%		-3.198M
-32.72%		-3.464M
-6.47%		-3.598M
-23.75%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CNSP Yearly Revenue VS EstimatesCNSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 50M 100M 150M 200M
CNSP Yearly EPS VS EstimatesCNSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -100K -200K -300K -400K -500K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.71%
EPS Next 5 Year
18.13%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CNS PHARMACEUTICALS INC / CNSP Forecast FAQ

Can you provide the average price target for CNS PHARMACEUTICALS INC stock?

8 analysts have analysed CNSP and the average price target is 53.04 USD. This implies a price increase of 2073.77% is expected in the next year compared to the current price of 2.44.

What is the next earnings date for CNSP stock?

CNS PHARMACEUTICALS INC (CNSP) will report earnings on 2026-03-30, after the market close.

What are the consensus estimates for CNS PHARMACEUTICALS INC (CNSP) next earnings?

The consensus EPS estimate for the next earnings of CNS PHARMACEUTICALS INC (CNSP) is -5.19 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for CNS PHARMACEUTICALS INC (CNSP) stock?

The consensus rating for CNS PHARMACEUTICALS INC (CNSP) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.